Cargando…

Association of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 With Angiotensin II Type 1 Receptor Impacts Mitochondrial Quality Control, Offering Promise for the Treatment of Vascular Senescence

Lectin-like oxidized low-density lipoprotein (ox-LDL) causes vascular senescence and atherosclerosis. It has been reported that ox-LDL scavenger receptor-1 (LOX-1) is associated with the angiotensin II type 1 receptor (AT1R). While mitochondria play a crucial role in the development of vascular sene...

Descripción completa

Detalles Bibliográficos
Autores principales: Uchikado, Yoshihiro, Ikeda, Yoshiyuki, Sasaki, Yuichi, Iwabayashi, Masaaki, Akasaki, Yuichi, Ohishi, Mitsuru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637926/
https://www.ncbi.nlm.nih.gov/pubmed/34869701
http://dx.doi.org/10.3389/fcvm.2021.788655
_version_ 1784608847603695616
author Uchikado, Yoshihiro
Ikeda, Yoshiyuki
Sasaki, Yuichi
Iwabayashi, Masaaki
Akasaki, Yuichi
Ohishi, Mitsuru
author_facet Uchikado, Yoshihiro
Ikeda, Yoshiyuki
Sasaki, Yuichi
Iwabayashi, Masaaki
Akasaki, Yuichi
Ohishi, Mitsuru
author_sort Uchikado, Yoshihiro
collection PubMed
description Lectin-like oxidized low-density lipoprotein (ox-LDL) causes vascular senescence and atherosclerosis. It has been reported that ox-LDL scavenger receptor-1 (LOX-1) is associated with the angiotensin II type 1 receptor (AT1R). While mitochondria play a crucial role in the development of vascular senescence and atherosclerosis, they also undergo quality control through mitochondrial dynamics and autophagy. The aim of this study was to investigate (1) whether LOX-1 associates with AT1R, (2) if this regulates mitochondrial quality control, and (3) whether AT1R inhibition using Candesartan might ameliorate ox-LDL-induced vascular senescence. We performed in vitro and in vivo experiments using vascular smooth muscle cells (VSMCs), and C57BL/6 and apolipoprotein E-deficient (ApoE KO) mice. Administration of oxidized low-density lipoprotein (ox-LDL) to VSMCs induced mitochondrial dysfunction and cellular senescence accompanied by excessive mitochondrial fission, due to the activation of fission factor Drp1, which was derived from the activation of the Raf/MEK/ERK pathway. Administration of either Drp1 inhibitor, mdivi-1, or AT1R blocker candesartan attenuated these alterations. Electron microscopy and immunohistochemistry of the co-localization of LAMP2 with TOMM20 signal showed that AT1R inhibition also increased mitochondrial autophagy, but this was not affected by Atg7 deficiency. Conversely, AT1R inhibition increased the co-localization of LAMP2 with Rab9 signal. Moreover, AT1R inhibition-induced mitochondrial autophagy was abolished by Rab9 deficiency, suggesting that AT1R signaling modulated mitochondrial autophagy derived from Rab9-dependent alternative autophagy. Inhibition of the Raf/MEK/ERK pathway also decreased the excessive mitochondrial fission, and Rab9-dependent mitochondrial autophagy, suggesting that AT1R signaling followed the Raf/MEK/ERK axis modulated both mitochondrial dynamics and autophagy. The degree of mitochondrial dysfunction, reactive oxygen species production, vascular senescence, atherosclerosis, and the number of fragmented mitochondria accompanied by Drp1 activation were all higher in ApoE KO mice than in C57BL/6 mice. These detrimental alterations were successfully restored, and mitochondrial autophagy was upregulated with the administration of candesartan to ApoE KO mice. The association of LOX-1 with AT1R was found to play a crucial role in regulating mitochondrial quality control, as cellular/vascular senescence is induced by ox-LDL, and AT1R inhibition improves the adverse effects of ox-LDL.
format Online
Article
Text
id pubmed-8637926
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-86379262021-12-03 Association of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 With Angiotensin II Type 1 Receptor Impacts Mitochondrial Quality Control, Offering Promise for the Treatment of Vascular Senescence Uchikado, Yoshihiro Ikeda, Yoshiyuki Sasaki, Yuichi Iwabayashi, Masaaki Akasaki, Yuichi Ohishi, Mitsuru Front Cardiovasc Med Cardiovascular Medicine Lectin-like oxidized low-density lipoprotein (ox-LDL) causes vascular senescence and atherosclerosis. It has been reported that ox-LDL scavenger receptor-1 (LOX-1) is associated with the angiotensin II type 1 receptor (AT1R). While mitochondria play a crucial role in the development of vascular senescence and atherosclerosis, they also undergo quality control through mitochondrial dynamics and autophagy. The aim of this study was to investigate (1) whether LOX-1 associates with AT1R, (2) if this regulates mitochondrial quality control, and (3) whether AT1R inhibition using Candesartan might ameliorate ox-LDL-induced vascular senescence. We performed in vitro and in vivo experiments using vascular smooth muscle cells (VSMCs), and C57BL/6 and apolipoprotein E-deficient (ApoE KO) mice. Administration of oxidized low-density lipoprotein (ox-LDL) to VSMCs induced mitochondrial dysfunction and cellular senescence accompanied by excessive mitochondrial fission, due to the activation of fission factor Drp1, which was derived from the activation of the Raf/MEK/ERK pathway. Administration of either Drp1 inhibitor, mdivi-1, or AT1R blocker candesartan attenuated these alterations. Electron microscopy and immunohistochemistry of the co-localization of LAMP2 with TOMM20 signal showed that AT1R inhibition also increased mitochondrial autophagy, but this was not affected by Atg7 deficiency. Conversely, AT1R inhibition increased the co-localization of LAMP2 with Rab9 signal. Moreover, AT1R inhibition-induced mitochondrial autophagy was abolished by Rab9 deficiency, suggesting that AT1R signaling modulated mitochondrial autophagy derived from Rab9-dependent alternative autophagy. Inhibition of the Raf/MEK/ERK pathway also decreased the excessive mitochondrial fission, and Rab9-dependent mitochondrial autophagy, suggesting that AT1R signaling followed the Raf/MEK/ERK axis modulated both mitochondrial dynamics and autophagy. The degree of mitochondrial dysfunction, reactive oxygen species production, vascular senescence, atherosclerosis, and the number of fragmented mitochondria accompanied by Drp1 activation were all higher in ApoE KO mice than in C57BL/6 mice. These detrimental alterations were successfully restored, and mitochondrial autophagy was upregulated with the administration of candesartan to ApoE KO mice. The association of LOX-1 with AT1R was found to play a crucial role in regulating mitochondrial quality control, as cellular/vascular senescence is induced by ox-LDL, and AT1R inhibition improves the adverse effects of ox-LDL. Frontiers Media S.A. 2021-11-17 /pmc/articles/PMC8637926/ /pubmed/34869701 http://dx.doi.org/10.3389/fcvm.2021.788655 Text en Copyright © 2021 Uchikado, Ikeda, Sasaki, Iwabayashi, Akasaki and Ohishi. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Uchikado, Yoshihiro
Ikeda, Yoshiyuki
Sasaki, Yuichi
Iwabayashi, Masaaki
Akasaki, Yuichi
Ohishi, Mitsuru
Association of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 With Angiotensin II Type 1 Receptor Impacts Mitochondrial Quality Control, Offering Promise for the Treatment of Vascular Senescence
title Association of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 With Angiotensin II Type 1 Receptor Impacts Mitochondrial Quality Control, Offering Promise for the Treatment of Vascular Senescence
title_full Association of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 With Angiotensin II Type 1 Receptor Impacts Mitochondrial Quality Control, Offering Promise for the Treatment of Vascular Senescence
title_fullStr Association of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 With Angiotensin II Type 1 Receptor Impacts Mitochondrial Quality Control, Offering Promise for the Treatment of Vascular Senescence
title_full_unstemmed Association of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 With Angiotensin II Type 1 Receptor Impacts Mitochondrial Quality Control, Offering Promise for the Treatment of Vascular Senescence
title_short Association of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 With Angiotensin II Type 1 Receptor Impacts Mitochondrial Quality Control, Offering Promise for the Treatment of Vascular Senescence
title_sort association of lectin-like oxidized low-density lipoprotein receptor-1 with angiotensin ii type 1 receptor impacts mitochondrial quality control, offering promise for the treatment of vascular senescence
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637926/
https://www.ncbi.nlm.nih.gov/pubmed/34869701
http://dx.doi.org/10.3389/fcvm.2021.788655
work_keys_str_mv AT uchikadoyoshihiro associationoflectinlikeoxidizedlowdensitylipoproteinreceptor1withangiotensiniitype1receptorimpactsmitochondrialqualitycontrolofferingpromiseforthetreatmentofvascularsenescence
AT ikedayoshiyuki associationoflectinlikeoxidizedlowdensitylipoproteinreceptor1withangiotensiniitype1receptorimpactsmitochondrialqualitycontrolofferingpromiseforthetreatmentofvascularsenescence
AT sasakiyuichi associationoflectinlikeoxidizedlowdensitylipoproteinreceptor1withangiotensiniitype1receptorimpactsmitochondrialqualitycontrolofferingpromiseforthetreatmentofvascularsenescence
AT iwabayashimasaaki associationoflectinlikeoxidizedlowdensitylipoproteinreceptor1withangiotensiniitype1receptorimpactsmitochondrialqualitycontrolofferingpromiseforthetreatmentofvascularsenescence
AT akasakiyuichi associationoflectinlikeoxidizedlowdensitylipoproteinreceptor1withangiotensiniitype1receptorimpactsmitochondrialqualitycontrolofferingpromiseforthetreatmentofvascularsenescence
AT ohishimitsuru associationoflectinlikeoxidizedlowdensitylipoproteinreceptor1withangiotensiniitype1receptorimpactsmitochondrialqualitycontrolofferingpromiseforthetreatmentofvascularsenescence